Home Biotech Stocks

Biotech Stocks

Latest

Insys Therapeutics Presents Study Results Showing Rapid Absorption Of Epinephrine

ME Staff - February 26, 2019

Veritas Pharma Doses First Subject In Clinical Study Of CTL-X

OWC Pharmaceutical Cannabis Ointment Set To Proceed To PII After Positive PI Data

Reliq Health Technologies Expands Leadership Team As Investigations Continue

Zynerba Gives Clinical Update, Lifelong Impact Of ZYN002

Another Win for RedHill – What’s Next?

ME Staff - June 16, 2015

Up-listing Could Prove Pivotal for Pieris

ME Staff - June 11, 2015

IPO Watch: ABIVAX in the Spotlight in Paris

ME Staff - June 9, 2015

Celgene Realigns Bluebird Collaboration; Good or Bad?

ME Staff - June 5, 2015

Xanthopoulos Steps down, Trouble Brewing for Regulus?

ME Staff - June 3, 2015

Clovis up on Ovarian Cancer, Lung Cancer Reports

ME Staff - June 1, 2015

Cellectis Up On Pfizer Rumors; A Good Time to Buy?

ME Staff - May 29, 2015

Accelerated Assessment Primes Amicus for a Billion Dollar Market

ME Staff - May 27, 2015

A Look at What Drove the Genocea Market Frenzy

ME Staff - May 25, 2015

Prima BioMed Ltd; Speculative Bubble or an Opportunity to Buy on...

ME Staff - May 22, 2015

1...144 145146Page 146 of 146

/* */

EDITOR PICKS

Cannabis Stock News Daily Roundup April 12

April 12, 2019

Market Morning: Alexa Spying, Boeing Sensor History, Macron Spoils Scallop Dinner

April 11, 2019

ICC, AgraFlora to Bring Native Colombian Cannabis Strains to 39K Retail...

April 10, 2019

Weekly Biotech Report covering – Opko Health Inc (NYSE:OPK) Intercept...

April 11, 2016

Facebook Inc – (NASDAQ:FB) Might Be Moving Away From Its...

April 8, 2016

Biotechnology Movers: Here’s Why Citius Pharmaceuticals Inc (NASDAQ:CTXR) Is Running Right...

November 8, 2017

ABOUT US

Market Exclusive offers the latest financial news and analysis for selected US stocks and securities. We are an investor driven research platform where new investment ideas from a exclusively selected group of seasoned investment analysts and qualified members from various disciplines are able to deliver their investment thesis’ across various industries and sectors. Our burgeoning team is comprised of individuals with strong backgrounds from various disciplines and businesses. Our goal is to provide an exclusive forum for contributors and users to leverage the knowledge base in order to make smarter investing decisions. At Market Exclusive, we believe that quality information from experienced well seasoned contributors provide our members with an edge that allows them to make wise investment choices. Market Exclusive is not a registered investment broker/dealer. The content on this site is for informational purposes only. Additionally, the content on this site does not represent the views of Market Exclusive and is solely a representation of the authors who publish them. Before investing in any security you should do your own due diligence and consult with a registered broker or financial advisor.